Retail investors who hold 25% of Anteris Technologies Global Corp. (ASX:AVR) gained 41%, institutions profited as well [Yahoo! Finance]
Anteris Technologies Global (NASDAQ:AVR) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises
Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock
Medtronic to buy up to $90M stake in heart valve developer Anteris [Yahoo! Finance]